Targeting Cytokines and Their Pathways for the Treatment of Cancer-Reference-Cited by-同舟云学术

Targeting Cytokines and Their Pathways for the Treatment of Cancer

Published:2023-10-30 Issue:21 Volume:15 Page:5224
ISSN:2072-6694
Container-title:Cancers
language:en
Short-container-title:Cancers

Author:

Heimberger Amy B.¹²^ORCID,Tripathi Shashwat¹²,Platanias Leonidas C.²³⁴

Affiliation:

1. Department of Neurological Surgery, Feinberg School of Medicine, Chicago, IL 60611, USA

2. Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL 60611, USA

3. Division of Hematology Oncology, Department of Medicine, Feinberg School of Medicine, Chicago, IL 60611, USA

4. Department of Medicine, Jesse Brown VA Medical Center, Chicago, IL 60612, USA

Abstract

This Special Issue focuses on the evolving role of immune modulatory cytokines, from their initial use as monotherapeutic recombinant proteins to their more contemporaneous use as modifiers for adoptive cellular immunotherapy [...]

Funder

National Cancer Institute

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Link

https://www.mdpi.com/2072-6694/15/21/5224/pdf

Reference61 articles.

1. Transfer factor in Hodgkin’s disease;Ng;Lancet,1975

2. Emerging principles of cytokine pharmacology and therapeutics;Saxton;Nat. Rev. Drug. Discov.,2023

3. The role of IL-6 in immunotherapy of non-small cell lung cancer (NSCLC) with immune-related adverse events (irAEs);Ke;Thorac. Cancer,2020

4. Sun, X., Qu, Q., Lao, Y., Zhang, M., Yin, X., Zhu, H., Wang, Y., Yang, J., Yi, J., and Hao, M. (2019). Tumor suppressor HIC1 is synergistically compromised by cancer-associated fibroblasts and tumor cells through the IL-6/pSTAT3 axis in breast cancer. BMC Cancer, 19.

5. STAT3 activation through IL-6/IL-11 in cancer-associated fibroblasts promotes colorectal tumour development and correlates with poor prognosis;Heichler;Gut,2020

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum Cytokines Correlate with Pretreatment Body Mass Index-adjusted Body Weight Loss Grading and Cancer Progression in Patients with Stage III Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Chemoradiotherapy Followed by Surgery;Nutrition and Cancer;2024-04-28

2. Immune Factors, Immune Cells and Inflammatory Diseases;International Journal of Molecular Sciences;2024-02-19

3. Navigating the Cytokine Seas: Targeting Cytokine Signaling Pathways in Cancer Therapy;International Journal of Molecular Sciences;2024-01-13